documents: FDA-2025-P-4282-0182
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2025-P-4282-0182 | FDA | FDA-2025-P-4282 | Reference 37 - Wagner et al - Clozapine Optimization A Delphi Consensus Guideline From the Treatment Response and Resistance in Psychosis Working Group | Supporting & Related Material | Background Material | 2026-02-24T05:00:00Z | 2026 | 2 | 2026-02-25T02:44:42Z | 0 | 0 | 09000064b91d3d89 |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref